NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qingdao Single-Cell Biotechnology Co., Ltd.

Qingdao Single-Cell Biotechnology Co., Ltd.

Private
QingdaoHealthcare & Life Scienceshttps://singlecellbiotech.com/

Last Round

Series A

Extension

Jan 19, 2026

Total Funding Raised

$18.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Qingdao Single-Cell Biotechnology Co., Ltd. is a biotechnology company that develops and commercializes single-cell medical and scientific instruments for metabolic phenome-based imaging, sorting, sequencing, and culture.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

single-cell analysisRaman-activated cell sortingRACSsingle-cell sequencingmetabolic phenotypingRaman spectroscopymicrobiome researchprecision medicineantimicrobial susceptibility testingASTbiotech instrumentationlabel-free imagingcell sortingsingle-cell omicslab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qingdao Single-Cell Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Qingdao Single-Cell Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qingdao Single-Cell Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 19, 2026
StrategicApr 23, 2024
Series ADec 12, 2023
Pre SeedJul 2, 2022

Qingdao Single-Cell Biotechnology Co., Ltd. Investors

Notable investors and investment history

Qingdao Single-Cell Biotechnology Co., Ltd. investors
InvestorRounds
Qingdao Zhongke Yucheng Investment Management Co., Ltd.Series A Extension
Beiyang Haitang Venture Capital FundSeries A
Zheshang CapitalSeries A Extension
Hengxu CapitalSeries A
Neovision CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 19, 2026

    $14M round with Zheshang Capital and Qingdao Zhongke Yucheng.

  • Jul 2, 2022

    $4M round led by Neovision Capital.

Qingdao Single-Cell Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qingdao Single-Cell Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qingdao Single-Cell Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersQingdao
Year FoundedN/A
Last FundingJan 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.